Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;44(12):1286-1295.
doi: 10.1111/aor.13783. Epub 2020 Aug 15.

Shear-dependent platelet aggregation size

Affiliations

Shear-dependent platelet aggregation size

Chris Hoi Houng Chan et al. Artif Organs. 2020 Dec.

Abstract

Nonsurgical bleeding is the most frequent complication of left ventricular assist device (LVAD) support. Supraphysiologic shear rates generated in LVAD causes impaired platelet aggregation, which increases the risk of bleeding. The effect of shear rate on the formation size of platelet aggregates has never been reported experimentally, although platelet aggregation size can be considered to be directly relevant to bleeding complications. Therefore, this study investigated the impact of shear rate and exposure time on the formation size of platelet aggregates, which is vital in predicting bleeding in patients with an LVAD. Human platelet-poor plasma (containing von Willebrand factor, vWF) and fluorochrome-labeled platelets were subjected to a range of shear rates (0-10 000 s-1 ) for 0, 5, 10, and 15 minutes using a custom-built blood-shearing device. Formed sizes of platelet aggregates under a range of shear-controlled environment were visualized and measured using microscopy. The loss of high molecular weight (HMW) vWF multimers was quantified using gel electrophoresis and immunoblotting. An inhibition study was also performed to investigate the reduction in platelet aggregation size and HMW vWF multimers caused by either mechanical shear or enzymatic (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13-ADAMTS13, the von Willebrand factor protease) mechanism under low and high shear conditions (360 and 10 000 s-1 ). We found that the average size of platelet aggregates formed under physiological shear rates of 360-3000 s-1 (200-300 μm2 ) was significantly larger compared to those sheared at >6000 s-1 (50-100 μm2 ). Furthermore, HMW vWF multimers were reduced with increased shear rates. The inhibition study revealed that the reduction in platelet aggregation size and HWM vWF multimers were mainly associated with ADAMTS13. In conclusion, the threshold of shear rate must not exceed >6000 s-1 in order to maintain the optimal size of platelet aggregates to "plug off" the injury site and stop bleeding.

Keywords: ADAMTS13; exposure time; platelet aggregate; shear rate; von Willebrand factor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest with the contents of this article.

Figures

FIGURE 1
FIGURE 1
A, A custom‐built blood‐shearing device was designed to be incorporated into a microscope. When the motor rotates, two opposite rotational motions are generated and transmitted to the sample chamber using pulleys and transmitting belts. B, Cross‐sectional view of the sample chamber: an acrylic bob and a glass plate that rotates in the opposite direction to generate shear Couette flow. The formation of platelet aggregates in the sample chamber was visualized in real‐time through the ×40 objective lens of the microscope [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 2
FIGURE 2
The effect of shear rate on average platelet aggregation size measured through microscopy (A‐D). Average platelet aggregation size formed under different shear rates of 0, 360, 1000, 3000, 6000, 10 000 s−1 at different exposure times. Results are described as mean ± standard deviation (SD), n = 5, *P < .05 [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 3
FIGURE 3
The effect of exposure time on average platelet aggregation size measured through microscopy (A‐D). Average platelet aggregation size formed under different shear rates at different exposure times of 0, 5, 10, and 15 minutes. Results are described as mean ± standard deviation (SD), n = 5, *P < .05 [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 4
FIGURE 4
A, von Willebrand factor (vWF) multimer analysis demonstrates high molecular weight (HMW) of vWF multimers degraded as the increasing a shear range of 0‐10 000 s−1 for an exposure time of 15 minutes. HMW of vWF multimers degraded (top dotted box) and low molecular weight (LMW) of vWF multimers accumulated as shear increased (bottom dotted box). B, High molecular weight von Willebrand factor (HMW vWF) density obtained from immunoblotting at shear range 0‐10 000 s−1 quantified using densitometry. HMV vWF density (360‐10 000 s−1) were normalized to the static result (0 s−1) as a baseline and described as mean ± standard deviation (SD), n = 5, *P < .05 [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 5
FIGURE 5
A, Average platelet aggregation size formed following shearing at 360 and 10 000 s−1 for an exposure time of 15 minutes with and without ethylenediaminetetraacetic acid (EDTA) (ADAMTS13 inhibitor) to determine the contribution between ADAMTS13 and the induced shear force on the reduced platelet aggregation size. Results are described as mean ± standard deviation (SD), n = 5, *P < .05. B, von Willebrand factor (vWF) multimer analysis demonstrates degradation of high molecular weight von Willebrand factor (HMW vWF) multimers following shearing at 360 and 10 000 s−1 for an exposure time of 15 minutes with and without EDTA (ADAMTS13 inhibitor) to determine the contribution between ADAMTS13 and the induced shear force on the degradation of HMW vWF multimers. Results are described as mean ± standard deviation (SD), n = 5, *P < .05 [Color figure can be viewed at wileyonlinelibrary.com]

References

    1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787–847. - PubMed
    1. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous‐flow left ventricular assist device. N Eng J Med. 2009;361:2241–51. - PubMed
    1. Proudfoot AG, Davidson SJ, Strueber M. von Willebrand factor disruption and continuous‐flow circulatory devices. J Heart Lung Transplant. 2017;36:1155–63. - PubMed
    1. Geisen U, Brehm K, Trummer G, Berchtold‐Herz M, Heilmann C, Beyersdorf F, et al. Platelet secretion defects and acquired von Willebrand syndrome in patients with ventricular assist devices. J Am Heart Assoc. 2018;7:e006519. - PMC - PubMed
    1. Katz JN, Adamson RM, John R, Tatooles A, Sundareswaran K, Kallel F, et al. Safety of reduced anti‐thrombotic strategies in HeartMate II patients: a one‐year analysis of the US‐TRACE study. J Heart Lung Transplant. 2015;34:1542–8. - PubMed

MeSH terms